Authors
Philip Villari, Vanessa Figueroa, Allison Scott, Michael Dingle, Tony Cundell, Petra Merker, M3 Collaboration
Published in
PDA journal of pharmaceutical science and technology. Volume 80. Issue 4. Pages 484-485. Aug 07, 2026. Epub Aug 07, 2026.
Abstract
Pharmaceutical manufacturers are implementing BFPC technology for in-process monitoring and control of unidirectional air flow in aseptic filling operations to improve cleanroom operations, thus enhancing sterility assurance and product quality. Continuous real-time monitoring is able to reduce the industry's reliance of growth-based methods for 5 to 7-day incubation periods to obtain results. A similar approach to surface and personnel monitoring is necessary to complete the environmental monitoring review for GMP batch release without the delay due to the traditional methods.This poster will offer an overview of what the M3 collaboration expects the vendor community to include when developing instrumentation for BFPC surface monitoring as part of the User Requirement Specification (URS). Key elements include the rationale for development, device description, business case, validation and calibration parameters, and desirable features.A major consideration is the ability to count Auto-fluorescent Units (AFU) per 25 cm2 on both flat facility surfaces and irregular ones (for example, needles, stopper tracks, stopper insertion pistons). This may require two sampling devices rather than one. The aim of our initiative is to streamline the development of a BFPC surface monitoring system; feedback on the value of the proposed URS will be gathered during the poster session.
PMID:
42567672
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 17
- Comments 0